Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael Bolliger"'
Autor:
Kerstin Wimmer, Stephanie Strobl, Michael Bolliger, Yelena Devyatko, Belgin Korkmaz, Ruth Exner, Florian Fitzal, Michael Gnant
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Background: The benefit of 5 years of adjuvant endocrine therapy for women with hormone receptor-positive (HR + ) breast cancer (BC) is beyond discussion. Nevertheless, the risk of recurrence of luminal BC persists for 15 years or more after diagnosi
Externí odkaz:
https://doaj.org/article/5d41cb35828748068782ff0317a1c41a
Autor:
Régis Resende Paulinelli, Walter P. Weber, Marta Bonollo, Ruth Helfgott, Yves Harder, Bärbel Papassotiropoulos, Dietmar Heck, E Trapp, Mathias K. Fehr, Zoltán Mátrai, Michael Bolliger, C. André, Elizabeth Morrow, Angelika Geroldinger, Hans-Jörg Fehrer, Florian Fitzal, Fabian Riedel, Jana de Boniface, Jens-Uwe Blohmer, Mathilde Ritter, Arvydas Burneckis, Pristauz Gunda, Katharina Lorenz, Christoph Tausch, Sander Steffen, Daniela Dunkler, Laszlo Romics, Dávid Pukancsik, Paliczek Clara, Valerijus Ostapenko, Andrej Ostapenko, Giacomo Montagna, Jörg Heil, Edvin Ostapenko, Markus Acko, Peter Schrenk, Francesco Meani, Andrea S M Alberti, Luca Gambone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256433ff329c6bb702d0b7945c8172cc
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-470785
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-470785
Autor:
Marta Bonollo, Andrej Ostapenko, Giacomo Montagna, Francesco Meani, Sander Steffen, Jörg Heil, Michael Bolliger, Paliczek Clara, Elizabeth Morrow, Pristauz-Telsnigg Gunda, Valerijus Ostapenko, Dietmar Heck, Zoltán Mátrai, Andrea S M Alberti, Luca Gambone, Markus Acko, C. André, Daniela Dunkler, Laszlo Romics, Dávid Pukancsik, Katharina Lorenz, Peter Schrenk, Jens-Uwe Blohmer, Florian Fitzal, Fabian Riedel, Edvin Ostapenko, Mathilde Ritter, Arvydas Burneckis, Yves Harder, Ruth Helfgott, Bärbel Papassotiropoulos, E Trapp, Christoph Tausch, Mathias K. Fehr, Régis Resende Paulinelli, Jana de Boniface, Hans-Jörg Fehrer, Angelika Geroldinger, Walter P. Weber
Publikováno v:
Annals of surgical oncology, Springer Science and Business Media Deutschland GmbH, 2022, vol. 29, no. 2, p. 1061-1070
Annals of Surgical Oncology
Annals of Surgical Oncology
Introduction Recent data suggest that margins ≥2 mm after breast-conserving surgery may improve local control in invasive breast cancer (BC). By allowing large resection volumes, oncoplastic breast-conserving surgery (OBCII; Clough level II/Tübing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0966551c620ffdb0c7a488aca2062548
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-470056
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-470056
Autor:
Michael Bolliger, Florian Fitzal, Andreas Gleiss, Pia Lanmüller, Michael Schütz, Tanja Keusch, Daniela Dörfler, Werner Haslik, Lena Theresa Maghörndl, Bernhard Heilig
Publikováno v:
Cancer Research. 80:P4-13
Introduction: Immediate techniques of oncoplastic surgery (iTOP) may be performed during breast conservation called oncoplastic breast conservation (OPBC) or skin/nipple sparing mastectomy defined as immediate breast reconstruction (IBR). There are n
Autor:
Michael Bolliger, Pia Lanmüller, Michael Schuetz, Bernhard Heilig, Amadeus Windischbauer, Raimund Jakesz, Tanja Zehetgruber, Michael Gnant, Andreas Gleiss, Daniela Dörfler, Christian Singer, Rupert Bartsch, Werner Haslik, Giacomo Montagna, Florian Fitzal
Publikováno v:
International journal of surgery (London, England). 104
Oncoplastic techniques allow resection of larger tumors, permitting breast conservation in cases otherwise requiring mastectomy. We sought to prospectively compare quality of life (QoL) in patients undergoing oncoplastic surgery as compared to conven
Autor:
Florian Fitzal, Valerijus Ostapenko, Daniela Dunkler, Fabian Riedel, Edvin Ostapenko, Laszlo Romics, Dávid Pukancsik, Francesco Meani, Katharina Lorenz, Zoltan Matrai, J-U Blohmer, Régis Resende Paulinelli, Yves Harder, Mathias K. Fehr, Sander Steffen, Arvydas Burneckis, Andrej Ostapenko, Giacomo Montagna, Marta Bonollo, Jörg Heil, Mathilde Ritter, Dietmar Heck, Hans-Jörg Fehrer, Peter Schrenk, C. André, Gunda Pristauz, Michael Bolliger, Walter P. Weber, Elizabeth Morrow, Markus Acko, C. Paliczek, J. de Boniface, Christoph Tausch, E Trapp, Ruth Helfgott, Bärbel Papassotiropoulos, Andrea S M Alberti, Luca Gambone
Publikováno v:
Breast, Vol 56, Iss, Pp S71-S72 (2021)
Autor:
Christoph Neumayer, Agnieszka Jabłońska, Josif Nanobachvili, Edyta Paradowska, Michael Bolliger, Bernd Gollackner, Markus Klinger, Ihor Huk
Publikováno v:
Journal of Vascular Surgery. 68:39S-46S
Objective Abdominal aortic aneurysm (AAA) is a vascular disease relatively common in the elderly population. Although some events that contribute to the development and progression of AAA are known, there are limited data examining the association of
Autor:
Michael Bolliger, Philipp Riss, F. Molineus, J.-A. Kroehnert, Monika Schindl, Daniela Kandioler
Publikováno v:
European Surgery
Summary Background The standardized Clavien-Dindo classification of surgical complications is applied as a simple and widely used tool to assess and report postoperative complications in general surgery. However, most documentation uses this classifi
Autor:
Ruth Exner, Michael Gnant, Michael Bolliger, Belgin Korkmaz, Kerstin Wimmer, Stephanie Strobl, Yelena Devyatko, Florian Fitzal
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 9 (2017)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: The benefit of 5 years of adjuvant endocrine therapy for women with hormone receptor-positive (HR+) breast cancer (BC) is beyond discussion. Nevertheless, the risk of recurrence of luminal BC persists for 15 years or more after diagnosis.
Autor:
Michael Bolliger, Svitlana Demyanets, Markus Klinger, Christoph Neumayer, Agnieszka Jabłońska, Ihor Huk, Christopher Burghuber, Josif Nanobachvili
Publikováno v:
Molecular biology reports. 47(4)
An abdominal aortic aneurysm (AAA) is a relatively common, life-threatening disease prevalent in persons over the age of 65. In recent years, an increasing number of studies have suggested that pattern-recognition receptors (PRRs), including Toll-lik